Journals / Türk Beyin Damar Hastalıkları Dergisi / 2022 / Cilt: 28 - Sayı: 1

CAPSULAR WARNING SYNDROME

KAPSÜLER UYARI SENDROMU

Pages
54–58
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we purposed to discuss three patients who presented with CWS followed with different treatment protocols

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Capsular warning syndrome (CWS) is a rare clinical syndrome, which is defined as a recurrent transient lacunar syndrome.
📊
Key Findings & Data:Because of its pathophysiology remains unclear, most effective treatment still cannot be defined.
💡
Conclusion & Impact:Here, we purposed to discuss three patients who presented with CWS followed with different treatment protocols
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Capsular warning syndrome (CWS) is a rare clinical syndrome, which is defined as a recurrent transient lacunar syndrome. Because of its pathophysiology remains unclear, most effective treatment still cannot be defined. Here, we purposed to discuss three patients who presented with CWS followed with different treatment protocols

Özet

Kapsüler uyarı sendromu (KUS), tekrarlayan geçici bir laküner sendrom olarak tanımlanan, nadir görülen bir klinik sendromdur. Patofizyolojisi hala yeterince anlaşılamayan bu sendromun en etkili tedavi konusu da belirsizliğini korumaktadır. Kliniğimizde takip edilen üç olgumuzda farklı tedavi protokolleri ile izlenmiş olup nadir görülmesi ve yönetimin zor olması nedeniyle sunmayı amaçladık.

🔖

Cite This Article

ŞENGEZE, N., YÜREKLİ, V. A., TÜRK, Ö. (2022). CAPSULAR WARNING SYNDROME. Türk Beyin Damar Hastalıkları Dergisi, Cilt: 28 - Sayı: 1, 54–58. https://ajindex.com/articles/620279

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Donnan GA, Bladin PF. Capsular warning syndrome-repetitive hemiplegia preceding capsular stroke. In Stroke 1987; 18(1): 296-296
  2. Sales C, Calma AD. Stroke warning syndrome. Clinical Neurology and Neurosurgery 2022; 213: 107120
  3. Donnan GA, O'Malley HM, Hurley S, et all. The capsular warning syndrome: pathogenesis and clinical features. Neurology 1993; 43(5): 957-957
  4. Staaf G, Geijer B, Lindgren A, et all. Diffusion-weighted MRI findings in patients with capsular warning syndrome. Cerebrovascular Diseases 2004; 17(1): 1-8
  5. Paul NL, Simon M, Chandratheva A, et all. Population-based study of capsular warning syndrome and prognosis after early recurrent TIA. Neurology 2012; 79(13): 1356-1362
  6. Camps-Renom P, Delgado-Mederos R, Martínez-Domeño A, et all. Clinical characteristics and outcome of the capsular warning syndrome: a multicenter study. International Journal of Stroke 2015; 10(4): 571-575
  7. Donnan GA, Tress BM, Bladin PF. A prospective study of lacunar infarction using computerized tomography. Neurology 1982; (1): 49-49
  8. Muengtaweepongsa S, Singh NN, Cruz-Flores S. Pontine warning syndrome: case series and review of literature. Journal of Stroke and Cerebrovascular Diseases 2010; 19(5): 353-356
  9. Von Bornstädt D, Houben T, Seidel JL, et all. Supply-demand mismatch transients in susceptible peri-infarct hot zones explain the origins of spreading injury depolarizations. Neuron 2015; 85(5): 1117-1131
  10. Selman WR, Lust WD, Pundik S, et all. Compromised metabolic recovery following spontaneous spreading depression in the penumbra. Brain research 2004; 999(2): 167-174
  11. Lindquist BE, Shuttleworth CW. Spreading depolarization-induced adenosine accumulation reflects metabolic status in vitro and in vivo. Journal of Cerebral Blood Flow & Metabolism 2014; 34(11): 1779-1790
  12. He L, Xu R, Wang J, et all. Capsular warning syndrome: clinical analysis and treatment. BMC neurology 2019; 19(1): 1-7
  13. Li W, Wu Y, Li XS, et all. Intravenous tirofiban therapy for patients with capsular warning syndrome. Stroke and vascular neurology 2019; 4(1): 22-27
  14. Tramacere I, Boncoraglio GB, Banzi R, et all. Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis. BMC medicine 2019; 17(1): 1-12
  15. Aznaouridis K, Masoura C, Vlachopoulose C, t all. Statins in Stroke. Curr Med Chem 2019; 26(33): 6174-6185
  16. Davignon J. Beneficial cardiovascular p